Is NEO or NOTV more undervalued in 2026?

CirclFi compares NeoGenomics, Inc. (NEO) and Inotiv, Inc. (NOTV) using 13 institutional-grade valuation models. NEO has a Quality of Company score of 6.8/10 while NOTV scores 5.5/10.

Which is a better buy — NEO or NOTV?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do NEO and NOTV valuations compare?

NEO at $10.19 and NOTV at $0.28 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

NEO vs NOTV Valuation Comparison 2026 — Intrinsic Value Analysis

NEO

Diagnostics & Research

NeoGenomics, Inc.

Quality

6.8

out of 10

Value Trap

LOW

Price

$10.19

Last close

Models

12/13

Active

NOTV

Diagnostics & Research

Inotiv, Inc.

Quality

5.5

out of 10

Value Trap

LOW

Price

$0.28

Last close

Models

1/13

Active

Model-by-Model Comparison

Model	Type	NEO Fair Value	NEO Upside	NOTV Fair Value	NOTV Upside
Bayesian DCF	Intrinsic	$0.46	-95.5%	—	—
Earnings Power Value	Intrinsic	$5.57	-41.0%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$2.08	-79.6%	$1.14	+303.6%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for NEO vs NOTV — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

NEO vs NOTV — Which Stock Is More Undervalued?

NEO scores higher with a 6.8/10 quality rating vs NOTV's 5.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing NeoGenomics, Inc. (NEO) and Inotiv, Inc. (NOTV) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

NEO currently trades at $10.19 with a QOC of 6.8/10, while NOTV trades at $0.28 with a QOC of 5.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).